Merck (MRK) reported fourth quarter and full-year earnings Tuesday, in line with Wall Street estimates. The bad news: Its stock was down more than 10% in early trading, largely because of weaker ...

Merck & Co. Inc.’s stock fell 3% Thursday, after the drug company beat profit and sales estimates for the third quarter, but ...

Merck (NYSE:MRK) shares fell nearly 8% Tuesday premarket after the pharma giant issued an outlook for the year that fell short of Wall Street estimates and said it is temporarily pausing shipments ...

Merck reported $64.2 billion in sales for 2024, a 7% increase compared with 2023. That is near Wall Street's consensus of $64 billion. Earnings per share came in at $7.65, just above Wall Street's ...